Mentice AB (FRA:MN2) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MN2 Mentice AB FRA:MN2
75 GF Score
Price €1.31
GF Value €1.94
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mentice AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:MN2 vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Mentice AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mentice AB Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mentice AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Mentice AB's Short Interest falls into.


FRA:MN2
75GF Score
Mentice AB FRA:MN2
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mentice AB (FRA:MN2) Overvalued in 2026?

Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued. The current stock price of €1.31 is trading 32.5% below its estimated GF Value™ of €1.94. GuruFocus considers Mentice AB to be Significantly Undervalued.

Key valuation signals for FRA:MN2:

  • Short Interest:
  • GF Value™: €1.94 vs. price of €1.31 (32.5% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the FRA:MN2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mentice AB Business Description

Other Exchanges MNTC:Sweden
Address Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
75GF Score

Get the complete analysis for FRA:MN2

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.31
Price
€1.94
GF Value